FDA official touts improved medtech approval process

04/22/2013 | Healio

The average time it takes to achieve a pre-market approval decision has dropped about one-third since 2010, while the time to clear medical devices submitted under the 510(k) process has improved about 30%, said Dr. Malvina Eydelman, director of the FDA's Division of Ophthalmic and Ear, Nose and Throat Devices, discussing her area of oversight. The change stems from certain improvements within the FDA, such as a simplified pre-market review process and greater FDA and industry collaboration, she said.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ